Angiotensin II inside and outside the brain: investigation on the mechanism of angiotensin II-induced
Angiotensin II inside and outside the brain: investigation on the mechanism of angiotensin II-induced
批准号:
17590593
负责人:
MIYOSHI Michio
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
我们研究了促炎症转录因子[核因子-κB(核因子-κB)和激活蛋白-1(AP-1)]是否有助于脑内依赖血管紧张素II(Ang II)的细胞因子的产生。有趣的是,我们发现一个单一的静脉注射。注射脂多糖对下丘脑、海马区和小脑区的核因子-κB和AP-1活性无明显影响(下丘脑AP-1活性降低)。此外,血管紧张素转换酶抑制剂和血管紧张素转换酶1型受体拮抗剂均增强(而不是降低)脂多糖诱导的大鼠海马区和(或)小脑中核因子-κB和AP-1的活性。这些结果似乎不支持核因子-κB和AP-1在血管紧张素Ⅱ诱导的大鼠脑内促炎症细胞因子的产生中起关键作用的观点。然而,整个脑细胞只有一部分被脑巨噬细胞、小胶质细胞占据。因此,我们随后调查了…进一步研究血管紧张素Ⅱ及其受体是否通过影响核因子-κB和AP-1的激活而参与内毒素诱导的小胶质细胞活化。为此,我们观察了血管紧张素转换酶受体拮抗剂氯沙坦对内毒素诱导的小胶质细胞产生白介素1(IL-1)和一氧化氮(NO)的影响、细胞的形态变化以及对小胶质细胞原代培养中核因子κB和AP-1活化的影响。我们的RT-PCR研究表明,脂多糖刺激的小胶质细胞有明显的ATI受体的mRNAs表达。脂多糖刺激的小胶质细胞IL-1和亚硝酸盐浓度升高,形态发生改变。这些作用均可被氯沙坦抑制。内毒素刺激的小胶质细胞中,NF-κB和AP-1的活性增强,而氯沙坦对其活性有明显的抑制作用。应用血管紧张素转换酶II本身可增强内毒素诱导的亚硝酸盐浓度升高。总之,这些结果提示,Ang II和AT_1受体可能通过激活转录因子、核因子-κB和AP-1 Less来刺激小胶质细胞,从而促进致热细胞因子的产生
英文摘要
We investigated whether proinflammatory transcription factors [nuclear factor-κB (NF-κB) and activator protein-1 (AP-1)] contribute to the angiotensin II (ANG II)-dependent production of cytokines within the brain. Interestingly, we found that a single i.c.v. injection of lipopolysaccharide (LPS) had no effect on NF-κB and AP-1 activities in the hypothalamus, hippocampus, and cerebellum (except for a decrease in hypothalamic AP-1 activity). Furthermore, both an angiotensin-converting-enzyme (ACE) inhibitor and an ANG type 1 (AT_1) receptor antagonist enhanced (rather than reduced) the NF-κB and AP-1 activities in the hippocampus and/or cerebellum of rats given LPS. These results seem not to support the idea that NF-κB and AP-1 play key roles in the ANG II-induced enhancement of the production of proinflammatory cytokines that is induced by LPS in the rat's brain. However, only a portion of whole brain cells is occupied by brain macrophage, microglial cells. Therefore, we then investiga … More ted whether ANG II and its receptors contributes to LPS-induced microglial activations through their effect on the activation of NF-κB and AP-1. To this end, examined were the effects of an ATI receptor antagonist, losartan, on the LPS-induced productions of interleukin-1 (IL-1) and nitric oxide (NO), morphological changes of the cells, as well as the activations of NF-κB and AP-1 in primary culture of microglial cells. Our RT-PCR study revealed that LPS-stimulated microglial cells had marked expression of mRNAs for ATI receptor. LPS-stimulated microglial cells showed increases in IL-1 and nitrite concentrations, as well as a morphological change. These effects were all inhibited by treatment with losartan. The activity of NF-κB and AP-1 was enhanced in LPS-stimulated microglial cells, that were significantly suppressed by losartan. Application of ANG II itself enhanced the LPS-induced increase in nitrite concentration. Collectively, these results suggest that the production of pyrogenic cytokines may be enhanced by ANG II and AT_1 receptor that stimulate microglial cells through the activation of transcription factors, NF-κB and AP-1 Less
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Effect of natriuretic peptide receptor antagonist on lipopolysaccharide-induced fever in rats. Is natriuretic peptide an endogenous antipyretic?
利钠肽受体拮抗剂对脂多糖所致大鼠发热的影响。
DOI:
--
发表时间:
2006
期刊:
Journal of Pharmacology and Experimental Therapeutics 318
影响因子:
--
作者:
[Miyoshi, M.]
通讯作者:
M.
DOI:
10.1016/j.bbrc.2006.09.034
发表时间:
2006-11
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Naoki Moriyama;M. Taniguchi;Kanako Miyano;M. Miyoshi;Tatsuo Watanabe]
通讯作者:
Naoki Moriyama;M. Taniguchi;Kanako Miyano;M. Miyoshi;Tatsuo Watanabe
Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-κB and AP-1 activities of rats given LPS
中枢注射血管紧张素转换酶抑制剂和血管紧张素1型受体拮抗剂对LPS大鼠脑NF-κB和AP-1活性的影响
DOI:
--
发表时间:
2006
期刊:
Peptides 27(6)
影响因子:
--
作者:
[Watanabe, K. et al.]
通讯作者:
K. et al.
Are transcription factors NF-kB and AP-1 involved in the ANG II-stimulated of proinflammatory cytokines induced by LPS in dehydrated rats?
转录因子 NF-kB 和 AP-1 是否参与脱水大鼠中 LPS 诱导的 ANG II 刺激的促炎细胞因子?
DOI:
--
发表时间:
2005
期刊:
AM J Physiol Regul Integr Comp Physiol 289
影响因子:
--
作者:
[Sasaki, K. et al.]
通讯作者:
K. et al.
Systemic administration of polymyxin B induces hypothermia in rats via an inhibitory effect on metabolic rate
全身给予多粘菌素 B 通过抑制代谢率诱导大鼠体温过低
DOI:
--
发表时间:
2006
期刊:
European Journal of Pharmacology 541(1-2)
影响因子:
--
作者:
[Moriyama, N. et al.]
通讯作者:
N. et al.
共 7 条
Exercise therapy for hypertension and diabetes mellitus: involvement of cross-adaptation to stress via inhibition of sympathetic nervous system
-
批准号:22500609
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2010
-
负责人:MIYOSHI Michio
-
依托单位:
Is angiotensin II involved in dehydration-enhanced fever induced by endotoxin in rats ?
-
批准号:12670060
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2000
-
负责人:MIYOSHI Michio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于肠道菌群探讨健脾化痰方通过调节LPS/NF-κB信号通路改善多囊卵巢综合征的机制研究
-
批准号:2026JJ80146
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:余曦明
-
依托单位:
基于肠道微生态的他莫昔芬-LPS-OTUD6A-HDAC3轴诱导乳腺癌内分泌治疗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:祝琦
-
依托单位:
基于4D Flow MRI 技术联合HA/cRGD-GD-LPs对比剂增强扫描诊断肝纤维化分期的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李刚静
-
依托单位:
基于肠道菌群介导的LPS/TLR4/NF-κB信号通路探讨针灸对脑缺血再灌注损伤大鼠的抑炎作用机制
-
批准号:2025JJ90298
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赖碧玉
-
依托单位:
肺炎克雷伯菌WaaLCPS连接酶相关的CPS-LPS合成通路及致病机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何平
-
依托单位:
半夏白术天麻汤通过抑制肠源性LPS/NF-κB通路减少NETs形成抗高血压血管内皮损伤的机制研究
-
批准号:KLY25H270034
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李波
-
依托单位:
基于“肠-肾轴”研究金花葵非药用部位经菌群-代谢物-TLR4/NF-κB调控LPS炎症小鼠的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:廖光琴
-
依托单位:
热灭活L.hilgardii通过Betaine募集MDSCs缓解LPS诱导急性肝损伤的机制研究
-
批准号:QN25H020022
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李学慧
-
依托单位:
噬菌体抑制LPS-TLR4-NF-κB信号通路纠
正菌群失衡在子痫前期发病中的机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:吕莉娟
-
依托单位:
肠杆菌Klebsiella pneumoniae衍生的LPS通过肝脏HADHA-K353乙酰化修饰加剧MASLD合并T2DM疾病进程的机制研究
-
批准号:2025JJ60788
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗武
-
依托单位: